{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-272936","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2024-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.854658+00:00","generated_at":"2026-05-29T05:30:44.957239+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Enanta reports positive Phase 2 data for zelicapavir in pediatric RSV: 1.4 log viral load drop at Day 5","bullets":["Part 2 primary endpoint: 1.4 log viral load decline at Day 5 vs placebo (n=34 zelicapavir, n=10 placebo).","Prespecified early-treatment subset (within 3 days of symptom onset): 1.2 log decline at Day 5 vs placebo.","96 patients (70 zelicapavir, 26 placebo) aged 28 days to 36 months; no AEs leading to discontinuation.","Dose selected: 5 mg/kg for ≥28 days to <12 months; 7.5 mg/kg for ≥12 to ≤36 months.","Symptom tool RESOLVE-P showed trend toward reduction but data available for only 15 patients."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-272936","json":"https://secwatch.observer/filing/0001193125-24-272936.json","markdown":"https://secwatch.observer/filing/0001193125-24-272936.md","text":"https://secwatch.observer/filing/0001193125-24-272936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312524272936/0001193125-24-272936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312524272936/d706648d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T05:30:44.957239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}